RALPH SNYDERMAN

CIK 1178031 · last filed 2025-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.85M

Companies

6

Total Filings

88

Lifetime Open-Market Net

-$2.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IRTC Director 13,288 $113.65 $1.51M -$97.9K 13 2025-05-29
CDNA Director 58,177 $22.97 $1.34M -$1.83M 44 2022-10-04
ARGOS THERAPEUTICS INC (ARGS) Delisted Director 573 $0 2 2017-01-04
Press Ganey Holdings, Inc. (PGND) Delisted Director 0 $0 3 2016-10-25
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Director 0 $0 2 2011-12-06
PROCTER & GAMBLE Co (PGw) Delisted Director 46,690 -$259.7K 14 2010-06-11

Recent Filings · Page 2 of 9

88 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-10 CDNA Sell (S) −9,500 -$761.8K EDGAR
2021-01-19 CDNA Sell (S) −12,000 -$1.07M EDGAR
2021-01-06 CDNA Grant (A) +215 $0 EDGAR
2020-10-02 CDNA Grant (A) +370 $0 EDGAR
2020-07-06 CDNA Grant (A) +557 $0 EDGAR
2020-07-06 CDNA Grant (A) +439 $0 EDGAR
2020-06-23 IRTC Grant (A) +1,056 $0 EDGAR
2020-06-23 Grant (A) $0
2020-06-19 CDNA Grant (A) +3,190 $0 EDGAR
2020-05-13 IRTC Sell (S) −250 -$33.6K EDGAR
Showing 1120 of 88
Page 2 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.